MR relaxometry in Huntington's disease: Correlation between imaging, genetic and clinical parameters

Journal of the Neurological Sciences

Volumn 263, Issue 1-2, 2007, Pages 20-25

  Vymazal, Josef ^a   Klempíř, Jiří ^b   Jech, Robert ^b   Židovská, Jana ^b   Syka, Michael ^a   Růžička, Evžen ^b   Roth, Jan ^b  

^a NA HOMOLCE HOSPITAL   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Brain iron; CAG triplet repeats; Ferritin; Huntington's disease; MRI; T2 relaxation; UHDRS

Indexed keywords

ADENINE; CYTOSINE; FERRITIN; GUANINE; IRON;

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; COVARIANCE; FEMALE; GENETIC ANALYSIS; GENETIC LOAD; GLOBUS PALLIDUS; HEALTH STATUS; HUMAN; HUNTINGTON CHOREA; MALE; MEDICAL PARAMETERS; METAL BINDING; NERVE FIBER TRANSPORT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING RELAXOMETRY; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

ADULT; AGED; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; FEMALE; HUMANS; HUNTINGTON DISEASE; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RELAXATION; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 35648936510     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.05.018     Document Type: Article

References (30)

1. Gusella J.F., Wexler N.S., Conneally P.M., Naylor S.L., Anderson M.A., Tanzi R.E., et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306 (1983) 234-238
2. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993, 72 971-983.
3. Charrin B.C., Saudou F., and Humbert S. Axonal transport failure in neurodegenerative disorders: the case of Huntington's disease. Pathol Biol (Paris) 53 (2005) 189-192
4. Gusella J.F., and MacDonald M.E. Huntingtin: a single bait hooks many species. Curr Opin Neurobiol 8 (1998) 425-430
5. Albin R.L. Selective neurodegeneration in Huntington's disease. Ann Neurol 38 (1995) 835-836
6. Vonsattel J.P., and DiFiglia M. Huntington disease. J Neuropathol Exp Neurol 57 (1998) 369-384
7. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., and Richardson Jr. E.P. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44 (1985) 559-577
8. Beglinger L.J., Nopoulos P.C., Jorge R.E., Langbehn D.R., Mikos A.E., Moser D.J., et al. White matter volume and cognitive dysfunction in early Huntington's disease. Cogn Behav Neurol 18 (2005) 102-107
9. Mascalchi M., Lolli F., Della Nave R., Tessa C., Petralli R., Gavazzi C., et al. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 232 (2004) 867-873
10. Rosas H.D., Koroshetz W.J., Chen Y.I., Skeuse C., Vangel M., Cudkowicz M.E., et al. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60 (2003) 1615-1620
11. Bartzokis G., Cummings J., Perlman S., Hance D.B., and Mintz J. Increased basal ganglia iron levels in Huntington disease. Arch Neurol 56 (1999) 569-574
12. Drayer B., Burger P., Darwin R., Riederer S., Herfkens R., and Johnson G.A. MRI of brain iron. AJR Am J Roentgenol 147 (1986) 103-110
13. Vymazal J., Hajek M., Patronas N., Giedd J.N., Bulte J.W., Baumgarner C., et al. The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration. J Magn Reson Imaging 5 (1995) 554-560
14. Vymazal J., Righini A., Brooks R.A., Canesi M., Mariani C., Leonardi M., et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 211 (1999) 489-495
15. Bartzokis G., and Tishler T.A. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell Mol Biol (Noisy-le-grand) 46 (2000) 821-833
16. Fahn S., and Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32 (1992) 804-812
17. Brustovetsky T., Purl K., Young A., Shimizu K., and Dubinsky J.M. Dearth of glutamate transporters contributes to striatal excitotoxicity. Exp Neurol 189 (2004) 222-230
18. McGahan M.C., Harned J., Mukunnemkeril M., Goralska M., Fleisher L., and Ferrell J.B. Iron alters glutamate secretion by regulating cytosolic aconitase activity. Am J Physiol Cell Physiol 288 (2005) C1117-C1124
19. Warner J.P., Barron L.H., and Brock D.J. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes 7 (1993) 235-239
20. Hallgren B., and Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 3 (1958) 41-51
21. Herynek V., Babis M., Trunecka P., Filip K., Vymazal J., Dezortova M., et al. Chronic liver disease: relaxometry in the brain after liver transplantation. Magma 12 (2001) 10-15
22. Sethi K.D. Magnetic resonance imaging in Huntington's disease. Mov Disord 6 (1991) 186
23. Jenkins B.G., Andreassen O.A., Dedeoglu A., Leavitt B., Hayden M., Borchelt D., et al. Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease. J Neurochem 95 (2005) 553-562
24. Hajek M., Adamovicova M., Herynek V., Skoch A., Jiru F., Krepelova A., et al. MR relaxometry and 1H MR spectroscopy for the determination of iron and metabolite concentrations in PKAN patients. Eur Radiol 15 (2005) 1060-1068
25. Vymazal J., Brooks R.A., Baumgarner C., Tran V., Katz D., Bulte J.W., et al. The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med 35 (1996) 56-61
26. Vymazal J., Bulte J.W., Frank J.A., Di Chiro G., and Brooks R.A. Frequency dependence of MR relaxation times. I. Paramagnetic ions. J Magn Reson Imaging 3 (1993) 637-640
27. Cross P.A., Atlas S.W., and Grossman R.I. MR evaluation of brain iron in children with cerebral infarction. AJNR Am J Neuroradiol 11 (1990) 341-348
28. Hilditch-Maguire P., Trettel F., Passani L.A., Auerbach A., Persichetti F., and MacDonald M.E. Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum Mol Genet 9 (2000) 2789-2797
29. Dexter D.T., Carayon A., Javoy-Agid F., Agid Y., Wells F.R., Daniel S.E., et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114 Pt 4 (1991) 1953-1975
30. Fennema-Notestine C., Archibald S.L., Jacobson M.W., Corey-Bloom J., Paulsen J.S., Peavy G.M., et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 63 (2004) 989-995